drugset / Trial / NCT01107496
Evaluation of Immediate-Release Viloxazine in Adults With ADHD
RandomizedParallel-groupQuadruple-blindOther
Summary
This will be a randomized, double-blind, placebo-controlled, parallel group, safety and tolerability study in adults with ADHD. The target subjects are healthy male or female adults aged 18 to 64 years, inclusive, with a diagnosis of ADHD.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Viloxazine | Small molecule | 100 mg | Oral |